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Abstract
Background: Withdrawal from chronic ethanol facilitates the formation of contextual fear memory and delays the onset 
to extinction, with its retrieval promoting an increase in ethanol consumption. Consequently, manipulations aimed to 
reduce these aversive memories, may be beneficial in the treatment of alcohol discontinuation symptoms.  Related to this, 
pharmacological memory reconsolidation blockade has received greater attention due to its therapeutic potential.
Methods: Here, we examined the effect of post-reactivation amnestic treatments such as Midazolam (MDZ, 3 mg/kg i.p) and 
Propranolol (PROP, 5 mg/kg i.p) on contextual fear memory reconsolidation in ethanol- withdrawn (ETOH) rats. Next, we examined 
whether the activation of N-methyl-D-aspartate (NMDA) receptors induced by d-cycloserine (DCS, 5 mg/kg i.p., a NMDA partial 
agonist) before memory reactivation can facilitate the disruptive effect of PROP and MDZ on fear memory in ETOH rats.
Results: We observed a resistance to the disruptive effect of both MDZ and PROP following memory reactivation. Although 
intra-basolateral amygdala (BLA; 1.25 ug/side) and systemic PROP administration attenuated fear memory in DCS pre-treated 
ETOH rats, DCS/MDZ treatment did not affect memory in these animals. Finally, a decrease of both total and surface protein 
expression of the α1 GABAA receptor (GABAA-R) subunit in BLA was found in the ETOH rats.
Conclusions: Ethanol withdrawal facilitated the formation of fear memory resistant to labilization post-reactivation. 
DCS administration promoted the disruptive effect of PROP on memory reconsolidation in ETOH rats. The resistance to 
MDZ’s disruptive effect on fear memory reconsolidation may be, at least in part, associated with changes in the GABAA-R 
composition induced by chronic ethanol administration/withdrawal.
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Introduction
Ethanol withdrawal syndrome is characterized by the presence 
of somatic signs and the emergence of negative affective states, 
including increased anxiety, dysphoria, and anhedonia, among 
others (Markou et al., 1998). Disturbances in the affective states 
in withdrawn subjects can persist for protracted periods of 
time, thus playing an important role in relapse and, in turn, the 
maintenance of addiction (Koob and LeMoal, 2001; Heilig et al., 
2010). In animal studies, an increased anxiety-like behavior, a 
heightened response to stressful stimuli, and increased ethanol 
consumption have also been documented during both the early 
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and protracted phases of withdrawal (Heilig, 2010). In addition, 
ethanol withdrawal alters learning and memory processes (Tipps 
et  al., 2013). Related to this, we have reported that withdrawal 
from chronic ethanol administration facilitates the formation of 
contextual fear memory, which is resistant to extinction (Bertotto 
et al., 2006). Furthermore, we have shown that the retrieval of fear 
memory increased ethanol consumption in ethanol-withdrawn 
rats (Bertotto et  al., 2010). Therefore, interventions to reduce 
aversive memories could be beneficial for the treatment of those 
symptoms and disturbances associated with alcohol withdrawal.
A growing amount of evidence has shown that consolidated 
fear memories can enter a transient labile phase upon retrieval. 
Following this phase, memories undergo a re-stabilization period 
dependent on new protein synthesis, referred to as reconsolidation 
(Nader et al., 2000; Alberini, 2005; Dudai, 2006). The administration 
of pharmacological agents during this unstable phase can affect 
the memory trace, with the disruption of memory reconsolida-
tion having been suggested as a potential treatment for anxiety-
related disorders and drug addiction (Tronson and Taylor, 2013). 
For instance, it has been shown that the post-reactivation admin-
istration of propranolol (β-adrenoceptor antagonist, PROP) or 
benzodiazepines (BZDs, positive allosteric modulators of GABA-A 
receptors [GABAA-Rs]) disrupts reconsolidation of fear memories 
(Debiec and LeDoux, 2004; Bustos et al., 2006). However, much less 
is known about the neural and behavioral basis of fear memory 
reconsolidation following drug withdrawal. Therefore, the first goal 
of the current study was to examine the effect of benzodiazepine 
midazolam (MDZ) and PROP administration on contextual fear 
memory reconsolidation in ethanol-withdrawn animals.
Diverse studies have suggested that there are certain condi-
tions that place constraints on the onset of the recall-induced 
fragility and, therefore, the reconsolidation process (Tronson 
and Taylor, 2007). Thus, a robust fear memory induced either 
following intensive training or after experiencing stressful stim-
uli remains unaffected by BZDs or anisomycin upon retrieval 
(Wang et al., 2009; Bustos et al., 2010). However, resistant mem-
ories can become susceptible to disruption by the activation of 
NMDA receptors prior to recall. For example, Bustos et al. (2010) 
demonstrated that D-cycloserine (DCS), a partial agonist of the 
glycine recognition site of the NMDA receptor, promoted vul-
nerability to MDZ´s disruptive effects in resistant fear memory 
prior to reactivation. Given that withdrawal from ethanol facili-
tates the formation of a robust and persistent fear memory, we 
can predict a resistance to the reconsolidation-blocking effects 
of both MDZ and PROP. Therefore, it seems relevant to evaluate 
the influence of pre-retrieval DCS administration on MDZ´s and 
PROP´s disruptive effects on fear memory reconsolidation in 
withdrawn rats. As the basolateral amygdala (BLA) complex is 
one of the main structures involved in fear memory reconsoli-
dation, we investigated the effect of PROP infused into the BLA 
in ethanol-withdrawn rats (Debiec and LeDoux, 2004).
GABA-A receptors are presumed to be heteropentamers 
composed of two α, two β, and one γ subunit, with the α1β2γ2 
subunit combination being highly expressed in the amygdala 
(McDonald and Mascagni, 2004). It is well known that GABAA-Rs 
are involved in the learning and memory processes (Makkar 
et  al., 2010) and that α1-containing receptors have a critical 
role in fear learning and plasticity in the amygdala (Heldt and 
Ressler, 2007; Wiltgen et  al., 2009). Furthermore, the amnestic 
effects of BZDs in aversive motivated tasks have been attrib-
uted to α1-containing receptors in this structure (Mohler et al., 
2002), with it being reported that ethanol withdrawal decreases 
the expression of the α-1 GABAA-R subunit in the amyg-
dala (Papadeas et al., 2001; Floyd et al., 2004; Diaz et al., 2011).
Therefore, an attenuated response to the amnestic effect of MDZ 
would be expected in ethanol-withdrawn rats. In the present 
study, we also examined the influence of ethanol withdrawal on 
the total and surface expression of the α1 subunit in the BLA.
Methods
Animals
Male Wistar rats from our breeding stock, weighing 240–260 g, were 
housed in groups of 3 per cage (Bertotto et al., 2006), with food and 
water ad libitum except when detailed otherwise in the protocol. 
Animals were maintained in a 12 h light-dark cycle (lights on at 
0700 h) at a room temperature of 21–22°C. The protocols used were 
approved by the Animal Care Committee of the Facultad de Ciencias 
Químicas, Universidad Nacional de Córdoba, and are consistent 
with the NIH Guide for the Care and Use of Laboratory animals.
Chronic Ethanol Administration
Ethanol was administered via a nutritionally complete liquid 
diet (Abbott Laboratories B.V.), as previously described (Bertotto 
et al., 2006, 2010). Briefly, rats were randomly allocated into two 
groups, one receiving a non-ethanol-containing liquid diet (CON) 
and the other one exposed to a diet containing 6% (v/v) ethanol 
for 14 days (ETOH). All rats received the diet without ethanol for 
an initial 3-day period, with water available ad libitum throughout 
the treatment. Dextrose was isocalorically substituted for ethanol 
in the CON group. These diets were removed at 0700 h on the day 
of withdrawal, and the animals were fed with laboratory chow 
for the rest of the experiments. This treatment resulted in blood 
ethanol levels from 87 to 146 mg/dl at the end of the treatment.
Drug Administration
Midazolam (GobbiNovag S.A.) was diluted in sterile saline (SAL, 
0.9% w/v) to a concentration of 3 mg/ml and given intraperito-
neally (i.p; Bustos et al., 2010).
DL-Propranolol hydrochloride and D-cycloserine (Sigma-
Aldrich) were both dissolved in SAL at concentrations of 10 mg/ml 
and 5 mg/ml, respectively, for i.p. injection (Debiec and LeDoux, 
2004; Bertotto et al., 2006; Muravieva et al., 2010). The total volume 
of drug or an equivalent amount of SAL was 1.0 ml/kg in all cases.
For intra-BLA infusions, PROP was dissolved in SAL to a final 
dose of 5 ug/ul and the amount infused was 1.25 ug/side (Debiec 
and LeDoux, 2004).
Crosslinking BS3
To examine surface expression of the α1 GABAA-R subu-
nit, we used the membrane-impermeable cross-linker 
bis(sulfosuccinimidyl)suberate (BS3; Thermo Fisher Scientific), 
as previously described (Boudreau et  al., 2012). Animals were 
sacrificed and the bilateral BLA was dissected from coronal 
brain slices of 2 mm using an acrylic brain matrix (Stoelting CO.) 
on ice, according to the BLA boundaries defined by Paxinos and 
Watson (2009). These samples were prepared from pools of 2 
animals. Next, the BLA tissue was chopped and the sample was 
immediately divided into two equal portions, of which one was 
incubated with BS3 in artificial cerebrospinal fluid (ACSF) and 
the other was incubated in ACSF only (untreated portion), for 
30 min at 4°C. Then, both samples were treated as described by 
Boudreau et al. (2012). BS3 does not cross the cell membranes, 
thereby enabling it to selectively cross-link surface-expressed 
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proteins with sulphide bonds and form high molecular weight 
aggregates, while the intracellular proteins remained unmodi-
fied. This reaction allows surface and intracellular pools of pro-
tein to be distinguished based on molecular weight for Western 
blot analysis, with the difference between the intracellular frac-
tion and the untreated portion (total protein) representing the 
surface pool (Diaz et al., 2011; Suryanarayanan et al., 2011).
Western Blot
Protein samples (15 μg) were separated on 7.5% sodium dode-
cyl sulfate -polyacrylamide gel electrophoresis and transferred 
to nitrocellulose membranes as previously described (Bertotto 
et al., 2011). The protein blots were incubated with a rabbit poly-
clonal primary antibody GABAA-R α1-subunit (1:750; Millipore), 
followed by incubation with horse radish peroxidase-conju-
gated anti-rabbit secondary antibody (1:2500, Cell Signaling 
Technology). The resulting film samples were scanned and ana-
lyzed with an image analysis program (Gelpro31). Actin (Sigma) 
was used as a loading control.
Surgery
Intra-BLA cannulae implantation and histological procedures 
were described in Giachero et al. (2013). The coordinates relative 
to bregma used were: anterior, -3 mm; lateral, ±5.0 mm; ventral, 
-6.1 mm (Paxinos and Watson, 2009), with only those animals with 
adequate injection sites being considered for statistical analysis.
Intra-BLA Infusions
The procedure for intra-BLA infusion was described in Giachero 
et al. (2013). Each rat was bilaterally infused with PROP or SAL at 
a flow rate of 0.25 μl/min. After completion of this volume injec-
tion, the infusion cannulas were kept in place for an additional 
period of 60 s to allow diffusion of the drug.
Contextual Fear Conditioning
Apparatus
The conditioning chamber was constructed of gray acrylic 
(20 × 23 × 20 cm) with a transparent lid and connected to a scram-
bled shocker (Ugo Basile Biological Research Apparatus). The 
grid floor consisted of 10 parallel stainless-steel grid bars, each 
measuring 4 mm in diameter and spaced 1.5 cm apart (center 
to center). The chamber was placed in a room illuminated by a 
white fluorescent tube located on the ceiling, which was cleaned 
before and after each session, with background noise being sup-
plied by ventilation fans and shock scramblers. The training and 
test sessions were conducted between 0900 and 1300 h.
Fear Conditioning
On the day of conditioning, rats were moved from their hous-
ing room and individually placed in the conditioning chamber. 
Animals were then left undisturbed for a 3 min acclimatization 
period (pre-shock period), followed by 3 unsignaled scrambled 
foot shocks (0.5 mA, 3 s duration, and 30 s intershock interval). 
Animals remained in the chamber for an additional 50 s (post-
shock period), before being immediately brought back to their 
home cages and returned to the colony room. Cannulated rats 
were trained with 3 foot shocks of 0.65 mA in order to induce 
levels of conditioning similar to those exhibited by non-can-
nulated rats, because chronic cannulation of the BLA tends to 
attenuate the expression of conditioned freezing (Fendt, 2001). 
The fear training protocol employed induced a similar freezing 
response in both control and ETOH groups. Therefore, we dis-
card the possibility that the differences obtained following the 
pharmacological treatments evaluated in the present study are 
dependent on the expression of freezing.
Re-Exposure Session (Reactivation Session)
One day following training, rats were re-exposed to the training 
context, without shock delivery, for 3 or 5 min depending on the 
experiment performed.
Test Sessions 
One (Test 1) and eight (Test 2) days after the reactivation session, 
animals were reintroduced into the training context without 
shock delivery for 10 min.
The freezing response of each rat was scored during the pre-
shock and post-shock periods and also in the reactivation and 
testing sessions. The total time spent freezing in each period 
was quantified (in seconds) using a stopwatch. Freezing, a com-
monly used index of fear in rats (Blanchard and Blanchard, 1969), 
was defined as the total absence of body and head movement 
except that associated with breathing. Freezing was scored by 
a person who was unaware of the experimental conditions of 
each animal.
Experimental Design
Experiment 1
This experiment was designed to test whether fear memory was 
vulnerable to MDZ´s and PROP´s disruptive effect in ETOH rats.
Animals assigned to CON or ETOH groups received the con-
textual fear training on the third day of withdrawal (Bertotto 
et.al, 2006). The following day, rats were subjected to the reac-
tivation session for 3 or 5 min. Immediately after, rats were 
injected with MDZ (3 mg/kg, i.p.), PROP (10mg/kg, i.p), or SAL and 
tested 24 h later for memory retention (Test 1). Seven days after, 
all animals were re-tested (Test 2).
Separate groups of rats from the CON and ETOH groups, 
which were trained at the same time, received a MDZ, PROP, or 
SAL injection in the home cage and served as non-reactivated 
controls. The retention tests were conducted as previously 
described.
Experiment 2
The goal of this experiment was to evaluate the influ-
ence of pre-reactivation DCS administration on MDZ´s and 
PROP´s disruptive effects on fear memory reconsolidation in 
ethanol-withdrawn rats.
Animals from the CON and ETOH groups were fear condi-
tioned as described in Experiment 1. One day after training, rats 
received DCS (5 mg/kg; i.p) or SAL 30 min before a 5 min reacti-
vation session. Immediately after, rats were injected with MDZ 
(3 mg/kg; i.p), PROP (10 mg/Kg, i.p), or SAL. Memory retention was 
evaluated the following day (Test 1) and one week later (Test 2).
Separate groups of rats from the CON and ETOH groups 
served as non-reactivated controls: they all had been trained at 
the same time, received DCS or SAL administration the next day, 
and received a MDZ, PROP, or SAL injection 30 min later in the 
home cage. The retention tests were conducted as previously 
described.
Experiment 3
In this experiment, we evaluated the effect of intra-BLA infusion 
of PROP on memory reconsolidation in DCS pre-treated rats.
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On the second day of withdrawal, CON and ETOH rats were 
bilaterally cannulated at the BLA; they were subjected to fear 
training 5 days later. One day after training, rats received DCS 
(5 mg/kg; i.p) or SAL 30 min before a 5 min reactivation session, 
and PROP (1.25 ug/side) or SAL was infused into the BLA after the 
end of this phase. The memory retention was evaluated on the 
following day and also one week later (Tests 1 and 2).
Additional groups of rats from the CON and ETOH groups 
that underwent the same conditioning and drug treatments in 
their home cages served as non-reactivated controls.
A longer interval between ethanol discontinuation and fear 
training was used, because cannulated rats need to have a 
recovery period of at least 5 days. Moreover, previous findings 
from our laboratory have shown that the influence of ethanol 
withdrawal on fear memory formation persists for at least up 
to two weeks following discontinuation (Bertotto et  al., 2006, 
2011).
Experiment 4
The purpose of this experiment was to examine the total and 
surface expression of the α1 GABAA-R subunit in the BLA fol-
lowing ethanol discontinuation. Animals were sacrificed for the 
crosslinking assay on the third day of withdrawal and then the 
expression of the α1 subunit was analysed by Western blot.
Statistical Analyses
Results were expressed as the means ± standard error of the 
mean. The data were analyzed by the Student’s t-test or analy-
ses of variance (ANOVAs) followed by Tukey honestly-significant- 
difference post hoc (p < 0.05 was regarded as significant).
Results
Experiment 1: Ethanol Withdrawal Enhanced the 
Resistance of Memory Trace to MDZ´s and PROP´s 
Disruptive Effects on Fear Memory Reconsolidation
As can be observed in Figure 1B, all animals displayed equiva-
lent levels of freezing during the 3 min reactivation session [F(1, 
31) = 1.93, p = 0.17]. The effect of MDZ injection after 3 min reac-
tivation is shown in Figure 1C, where during Test 1 a significant 
reduction of freezing was only detected in MDZ treated rats 
from the CON group. This effect lasted for up to one week (Test 
2). In contrast, MDZ did not affect the fear response in ETOH 
rats. ANOVA showed significant diet treatment x drug treat-
ment interactions for Test 1 [F(1, 31) = 42.63; p < 0.05] and Test 
2 [F(1,31) = 21.19; p < 0.05]. In both tests, the post hoc analysis 
revealed that CON-MDZ rats exhibited significantly less freezing 
than the remaining groups.
Because stronger memories may require longer retrieval 
durations to become sensitive to interference (Suzuki et  al., 
2004), we investigated whether increasing the duration of 
the reactivation session would favor MDZ´s disruptive effect 
on fear memory reconsolidation in ETOH rats. As depicted in 
Figure  1D, all animals assigned to test the disruptive effects 
of MDZ exhibited comparable levels of freezing during the 
5 min reactivation session [F(1, 20) = 1.92, p = 0.18]. As shown 
in Figure 1E, MDZ attenuated the freezing response in the CON 
group on Test 1, with this effect lasting for up to one week. In 
contrast, MDZ did not affect the freezing levels in the ETOH 
group. ANOVA revealed significant diet treatment x drug treat-
ment interactions for Test 1 [F(1,20) = 33.32; p < 0.05] and Test 
2 [F(1,20) = 33.05; p < 0.05]. In both tests, the post hoc analysis 
revealed that CON-MDZ rats exhibited significantly less freez-
ing than the remaining groups.
To increase the probability of memory interference, the dura-
tion of the reactivation session used in subsequent experiments 
was maintained at 5 min.
As depicted in Figure  1F, all animals assigned to test 
the disruptive effects of PROP exhibited comparable levels 
of freezing during the reactivation session [F(1, 32)  =  0.15, 
p  =  0.70]. The CON group that received post-reactivation 
PROP exhibited a reduced freezing on Test 1, which lasted 
for up to one week (Figure 1G). However, PROP did not affect 
the fear response in ETOH rats. ANOVA showed significant 
diet treatment x drug treatment interactions for Test 1 
[F(1,32) = 13.34; p < 0.05] and Test 2 [F(1,32) = 8.32; p < 0.05]. 
A  post hoc analysis revealed that CON rats injected with 
PROP exhibited significantly less freezing than the remain-
ing groups during both Test 1 and Test 2. All non-reactivated 
groups displayed similar levels of freezing, which did not dif-
fer from those shown by the reactivated groups during Test 
1 [F(1,25) = 0.28; p = 0.60 and F(1,33) = 0.05; p = 0.82; Figure 2B 
and C, respectively].
In summary, and regardless of the duration of the reacti-
vation session, neither MDZ nor PROP affected the freezing 
response during the retention tests in the ETOH groups.
Experiment 2: The Disruptive Effects of PROP But Not 
of MDZ on Memory Reconsolidation were Facilitated 
by Pre-Reactivation DCS Administration in Ethanol-
Withdrawn Rats
All rats showed comparable levels of freezing during the 5 min 
reactivation session [F(1,61) = 0.04; p  = 0.84 and F(1,54) = 0.04; 
p = 0.84; Figure 3B and D, respectively]. The effect of pre-reacti-
vation DCS administration on MDZ´s disruptive consequences 
on memory reconsolidation is shown in Figure  3C. Regardless 
of the drug injected before the reactivation session, a signifi-
cant decrease in fear response was detected in CON groups 
treated with MDZ. These effects lasted up to one week. However, 
none of the treatments affected the freezing response in ETOH 
rats. ANOVA revealed no significant diet treatment x pre-reac-
tivation drug x post-reactivation drug interaction for Test 1 
[F(1,61)  =  0.12; p  =  0.72] or Test 2 [F(1,61)  =  0.05; p  =  0.83], but 
significant diet treatment x post-reactivation drug interactions 
for Test 1 [F(1,61) = 40.24; p  <  0.05] and Test 2 [F(1,61) = 15.47; 
p < 0.05]. In both tests, the post hoc analysis of significant diet 
treatment x post-reactivation drug interaction revealed that the 
freezing levels of the MDZ-CON groups were significantly lower 
than the remaining groups.
The effect of pre-reactivation DCS administration on 
PROP´s disruptive effect on memory reconsolidation is shown 
in Figure 3E. Regardless of the treatment before the reactiva-
tion session, CON animals injected with PROP showed reduced 
levels of freezing. In the ETOH group, the DSC-PROP treatment 
elicited a decrease in the freezing levels that did not differ 
from those shown by the CON-PROP groups and that lasted 
up to one week. ANOVA revealed significant diet treatment 
x pre-reactivation drug x post-reactivation drug interactions 
for Test 1 [F(1,54)  =  6.38; p  <  0.05] and Test 2 [F(1,54)  =  6.44; 
p  <  0.05]. For both tests, the freezing levels of DCS-PROP 
and SAL-PROP from the CON group and DCS-PROP from the 
ETOH group did not differ from each other and were signifi-
cantly lower than the remaining groups. All non-reactivated 
groups displayed similar levels of freezing which did not vary 
from those shown by the reactivated groups during Test 1 
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[F(1,32) = 0.13; p = 0.72 and F(1,41) = 0.02; p = 0.90; Figure 4B 
and C, respectively].
Taken together, these results suggest that DCS/PROP treat-
ment was effective in reducing the freezing response in ETOH 
group, whereas the DCS/MDZ treatment was ineffective.
Experiment 3: Intra-BLA PROP Infusion Disrupted 
Memory Reconsolidation in Ethanol-Withdrawn Rats 
Treated with DCS Prior to Reactivation
As shown in previous experiments, all rats showed com-
parable levels of freezing during the reactivation session 
[F(1,45)  =  2.47; p  =  0.12; Figure  5B]. The effect of intra-BLA 
PROP on Test 1 and Test 2 is shown in Figure 5C. Regardless of 
the drug treatment before the reactivation session, the CON 
group infused with PROP revealed reduced levels of freezing. 
Intra-BLA PROP decreased the levels of freezing in DCS-ETOH 
rats, with the PROP effects lasting up to one week in both 
groups. ANOVA revealed significant diet treatment x pre-reac-
tivation drug x post-reactivation drug interactions for Test 1 
[F(1,45) = 11.84; p < 0.05] and Test 2 [F(1,45) = 9.45; p < 0.05]. In 
both tests, the levels of freezing for DCS-PROP and SAL-PROP 
from the CON group and DCS-PROP from the ETOH group did 
not differ from each other and were significantly lower than 
the remaining groups. All non-reactivated groups displayed 
similar levels of freezing, which did not vary from those 
Figure 1. Effect of systemic administration of MDZ and PROP following retrieval on contextual fear memory reconsolidation in ethanol-withdrawn rats. (A) Timeline for 
Experiment 1. (B) All groups exhibited comparable levels of freezing during the 3 min reactivation session. (C) Post-retrieval MDZ (3 mg/kg, i.p.) attenuated the freezing 
behavior on Test 1 and Test 2 in CON, but not in ETOH rats. CON-SAL (n = 9), CON-MDZ (n = 10), ETOH-SAL (n = 8), and ETOH-MDZ (n = 8). (D) All groups assigned to test 
the disruptive effect of MDZ on memory reconsolidation exhibited comparable levels of freezing during the 5 min reactivation session. (E) Post-retrieval MDZ (3 mg/kg, 
i.p.) attenuated the freezing behavior on Test 1 and Test 2 in CON, but not in ETOH rats. CON-SAL (n = 6), CON-MDZ (n = 6), ETOH-SAL (n = 6), and ETOH-MDZ (n = 6). (F) 
All groups assigned to test the disruptive effect of PROP on memory reconsolidation exhibited comparable levels of freezing during the 5 min reactivation session. (G) 
Post-retrieval PROP (10 mg/kg, i.p.) attenuated the freezing behavior on Tests 1 and 2 in CON, but not in ETOH rats. CON-SAL (n = 8), CON-PROP (n = 11), ETOH-SAL (n = 8), 
and ETOH-PROP (n = 9). Data are the mean ± standard error of the mean of time spent freezing during reactivation session, Test 1, and Test 2. *Significantly different 
from the remaining groups (p < 0.05). CON, control rats; ETOH, ethanol-withdrawn rats; MDZ, midazolam; PROP, propranolol; SAL, sterile saline.
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shown by the reactivated groups during Test 1 [F(1,33) = 0.10; 
p  =  0.75; Figure  5D]. The cannula placements are shown in 
Figure 6.
These results suggest that intra-BLA PROP infusion was 
effective in reducing the freezing response in ETOH rats that 
were treated with DCS.
Experiment 4: Ethanol Withdrawal Reduced Both 
the Total and Surface Expression of α 1 GABA-A 
Receptor Subunit in the BLA
In this experiment, we examined whether the lack of an amne-
sic effect of MDZ in ETOH rats could be attributed to changes in 
the total and/or surface expression of the α1 GABAA-R subunit 
in the BLA. Western blot analysis revealed a decreased total 
[t = 3.93; p  < 0.05] and surface expression [t = 2.86; p  < 0.05] 
of the GABAA-R α1 subunit at day 3 of withdrawal (Figure 7C 
and D).
Discussion
As expected, and in agreement with previous findings, the post-
retrieval systemic administration of either MDZ or PROP or 
PROP intra-BLA administration reduced freezing on subsequent 
memory tests in CON rats. This disruptive effect of MDZ and 
PROP was dependent on memory reactivation, since no amnes-
tic effect was observed in CON rats receiving these drugs in the 
absence of the reactivation session. It could be argued that the 
Figure 3. Influence of pre-retrieval DCS administration on MDZ’s and PROP’s disruptive effects on the reconsolidation of contextual fear memory in ethanol-withdrawn 
rats.(A) Timeline for Experiment 2. (B) Regardless of the pre-retrieval drug treatment, all groups of animals assigned to test the disruptive effect of MDZ on memory 
reconsolidation exhibited comparable levels of freezing during the 5 min reactivation session. (C) Pre-reactivation DCS (5 mg/kg, i.p.) did not facilitate the disruptive 
effect of MDZ (3 mg/kg, i.p.) on memory reconsolidation in ETOH rats. CON-SAL/SAL (n = 8), CON-SAL/MDZ (n = 8), CON-DCS/SAL (n = 8), CON-DCS/MDZ (n = 10), ETOH-
SAL/SAL (n = 8), ETOH-SAL/MDZ (n = 8), ETOH-DCS/SAL (n = 9), and ETOH-DCS/MDZ (n = 10). (D) Regardless of the pre-retrieval drug treatment, all group of animals 
assigned to test the disruptive effect of PROP on memory reconsolidation exhibited comparable levels of freezing during the 5 min reactivation session. (E) Pre-reacti-
vation DCS (5 mg/kg, i.p.) facilitated the disruptive effect of PROP (10 mg/kg, i.p.) on memory reconsolidation in ETOH rats. CON-SAL/SAL (n = 7), CON-SAL/PROP (n = 7), 
CON-DCS/SAL (n = 7), CON-DCS/PROP (n = 8), ETOH-SAL/SAL (n = 8), ETOH-SAL/PROP (n = 8), ETOH-DCS/SAL (n = 8), and ETOH-DCS/PROP (n = 9). Data are expressed as 
the mean ± standard error of the mean of time spent freezing during the reactivation session, Tests 1 and 2. *Significantly different from the remaining groups (p < 0.05). 
CON, control rats; DCS, d-cycloserine; ETOH, ethanol-withdrawn rats; MDZ, midazolam; PROP, propranolol; SAL, sterile saline.
Figure 2. Effect of systemic administration of MDZ and PROP on memory recon-
solidation in animals without memory reactivation.(A) Timeline for non-reacti-
vated rats from Experiment 1. (B and C) In the absence of the re-exposure ses-
sion, neither MDZ nor PROP, respectively, reduced the freezing response on Test 
1. (B) CON-SAL (n = 7), CON-MDZ (n = 7), ETOH-SAL (n = 7), and ETOH-MDZ (n = 8). 
(C) CON-SAL (n = 9), CON-PROP (n = 8), ETOH-SAL (n = 9), and ETOH-PROP (n = 11). 
Data are the mean ± standard error of the mean of time spent freezing during 
Test 1. CON, control rats; ETOH, ethanol-withdrawn rats; MDZ, midazolam; PROP, 
propranolol; SAL, sterile saline.
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reduction of freezing observed following such pharmacological 
treatments is due to facilitated extinction rather than disrupting 
reconsolidation. However, this possibility seems unlikely. In fact, 
the attenuation of freezing was maintained during the second 
test performed 1 week later, thus indicating the absence of fear 
recovery.
Also, it is well known that the activation of GABAA-Rs 
interferes with the acquisition and consolidation of extinc-
tion memory (Makkar et  al., 2010). Moreover, it is clear that 
PROP does not facilitate the onset of extinction memory (Cain 
et al., 2004; Rodriguez-Romaguera et al., 2009). Collectively, our 
results have replicated previous findings showing that MDZ or 
Figure 5. Effect of intra-BLA PROP on contextual fear memory reconsolidation in ethanol-withdrawn rats and the influence of DCS.(A) Timeline for Experiment 3. (B) 
Regardless of the pre-retrieval drug treatment, all groups of animals exhibited comparable levels of freezing during the 5 min reactivation session. (C) Pre-reactivation 
DCS (5 mg/kg, i.p.) facilitated the disruptive effect of intra-BLA PROP (1.25 ug/side) on memory reconsolidation in ETOH rats. CON-SAL/SAL (n = 7), CON-SAL/PROP (n = 6), 
CON-DCS/SAL (n = 6), CON-DCS/PROP (n = 7), ETOH-SAL/SAL (n = 7), ETOH-SAL/PROP (n = 6), ETOH-DCS/SAL (n = 7), and ETOH-DCS/PROP (n = 7). (D) In the absence of a 
reactivation session none of the drug treatments reduced the freezing response on Test 1. CON-SAL/SAL (n = 6), CON-SAL/PROP (n = 5), CON-DCS/SAL (n = 5), CON-DCS/
PROP (n = 5), ETOH-SAL/SAL (n = 5), ETOH-SAL/PROP (n = 5), ETOH-DCS/SAL (n = 5), and ETOH–DCS/PROP (n = 5). Data are the mean ± standard error of the mean of time 
spent freezing during reactivation session, Test 1, and Test 2. *Significantly different from the remaining groups (p < 0.05). BLA, basolateral amygdala; CON, control rats; 
DCS, d-cycloserine; ETOH, ethanol-withdrawn rats; PROP, propranolol; SAL, sterile saline.
Figure 4. Influence of DCS administration on MDZ’s and PROP’s effect on memory reconsolidation in animals without memory reactivation. (A) Timeline for non-reac-
tivated rats from Experiment 2. (B and C) In the absence of a re-exposure session, none of the drug treatments reduced the freezing response on Test 1. (B) CON-SAL/
SAL (n = 5), CON-SAL/MDZ (n = 5), CON-DCS/SAL (n = 5), CON-DCS/MDZ (n = 5), ETOH-SAL/SAL (n = 5), ETOH-SAL/MDZ (n = 5), ETOH-DCS/SAL (n = 5) and ETOH-DCS/
MDZ (n = 5). (C) CON-SAL/SAL (n = 7), CON-SAL/PROP (n = 7), CON-DCS/SAL (n = 6), CON-DCS/PROP (n = 6), ETOH-SAL/SAL (n = 7), ETOH-SAL/PROP (n = 6), ETOH-DCS/SAL 
(n = 5), and ETOH-DCS/PROP (n = 5). Data are the mean ± standard error of the mean of time spent freezing during Test 1. CON, control rats; DCS, d-cycloserine; ETOH, 
ethanol-withdrawn rats; MDZ, midazolam; PROP, propranolol; SAL, sterile saline.
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PROP given systemically, or PROP directly infused into the BLA 
following retrieval, results in the disruption of contextual fear 
memory reconsolidation in CON rats (Debiec and LeDoux, 2004; 
Bustos et al., 2006; Zhang and Cranney, 2008; Muravieva et al., 
2010). Interestingly, Debiec and LeDoux (2004) reported that the 
intra-amygdala administration of PROP impaired auditory fear 
memory reconsolidation. Taken together, these findings suggest 
that the β-adrenoreceptors (β-ARs) located in the BLA are also 
involved in contextual fear memory reconsolidation.
In contrast to the effects observed in CON rats, neither 
MDZ nor PROP (after either systemic or intra-BLA administra-
tion) attenuated the subsequent freezing response in ETOH rats 
(Figures 1 and 5). This lack of induced amnesia in these rats 
cannot be attributed to low drug dosage because MDZ (3 mg/kg) 
and PROP (at 10 mg/kg; 1.25 ug/side) had been the highest doses 
that were reported to be effective in studies involving memory 
reconsolidation blockade (Debiec and LeDoux, 2004; Bustos et al. 
2010; Muravieva et al., 2010). Taken together, our results suggest 
that a previous history of ethanol dependence/withdrawal leads 
to the generation of a fear memory trace that is less vulnerable 
to disruption after recall.
Evidence from other studies involving fear conditioning in 
rodents has demonstrated that stronger memories are more 
resistant to reconsolidation blockade than weaker memories. 
For instance, robust memories induced by increasing the num-
ber of shocks during acquisition, or by exposing animals to a 
stressful experience prior to fear acquisition, were resistant to 
reconsolidation interference (Suzuki et  al., 2004; Wang et  al., 
2009; Bustos et al., 2010). Interestingly, we have previously dem-
onstrated that the withdrawal from chronic alcohol exposure 
facilitated the formation of a robust contextual fear memory 
accompanied by impaired extinction (Bertotto et  al., 2006). In 
agreement with these findings, it was recently reported that 
withdrawal from chronic, intermittent ethanol administration 
also impaired auditory fear memory extinction (Holmes et al., 
2012). Given that the fear memory formed under ethanol with-
drawal is resistant to extinction and to pharmacological block-
ade following retrieval, our present results strongly support the 
notion that withdrawal from chronic ethanol, similar to previ-
ous stress exposure, strengthens fear memory formation.
Activation of NMDA receptors seems to play a major role in 
reactivation-induced fragility (Ben Mamou et al., 2006) and make 
these resistant memories, such as those formed under stress 
conditions, become more susceptible to disruption (Bustos et al., 
2010). Here, we show that DCS administration before memory 
reactivation was effective in inducing instability following 
retrieval, and in turn, promoting vulnerability to the disruptive 
Figure 7. Effect of ethanol withdrawal on total and surface protein expression of 
α1 GABAA-R subunit in the BLA.(A) Timeline for Experiment 4. (B) Representative 
immunoreactive bands of total and surface α1 GABAA-R subunit and actin in the 
BLA from the CON and ETOH groups. (C) Bars represent the total expression of α1 
in the BLA (n = 8/group). (D) Bars represent the surface expression of α1 in the BLA 
(n = 8/group). U, untreated portion; T, treated portion with bis(sulfosuccinimidyl)
suberate. *Significantly different from the CON group (p < 0.05). BLA, basolateral 
amygdala; CON, control rats; ETOH, ethanol-withdrawn rats.
Figure 6. Placement of infusion cannulas.(A) Photomicrograph of a coronal brain section showing the location of the infusion site in the BLA. Magnification: 25x. 
Schematic representation of coronal sections of the rat brain showing the cannula tip placements for reactivated groups (B) and non-reactivated groups (C) in the BLA 
for Experiment 3 (adapted from Paxinos and Watson, 2009). BLA, basolateral amygdala; CON, control rats; DCS, d-cycloserine; ETOH, ethanol-withdrawn rats; PROP, 
propranolol; SAL, sterile saline.
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effect of PROP (after either systemic or intra-BLA administra-
tion) on fear memory reconsolidation in ETOH rats (Figures 3 and 
5). This is based on four results: (1) PROP can induce memory 
interference in ETOH animals that received pre-reactivation DCS 
but not SAL; (2) the DCS/PROP treatment was ineffective in the 
absence of the re-exposure session, thus indicating that such 
interference is selectively dependent on memory reactivation; (3) 
DCS/PROP-treated ETOH rats displayed similar freezing levels to 
those exhibited by PROP-treated CON rats; and (4) DCS was inef-
fective in CON rats, because SAL/PROP and DCS/PROP rats exhib-
ited similar freezing during Test 1 and Test 2, thus supporting the 
contention that memory destabilization induced by DCS is selec-
tively promoted in those memories resistant to PROP´s disrup-
tive effect. Consistent with previous findings (Bustos et al., 2010; 
Lee et al., 2006), DCS administration before the brief reactivation 
session did not influence freezing expression, because all rats 
showed comparable levels of freezing during this trial. Although 
other evidence indicated that DCS facilitates the formation of 
extinction memory (Walker et al., 2002; Bertotto et al., 2006), this 
did not occur under our experimental conditions, because the 
DCS/SAL group from the CON rats exhibited high levels of freez-
ing during Test 1 and Test 2. The fact that the cannulated rats 
were fear trained 7 days after withdrawal, and that post-retrieval 
intra-BLA infusions of PROP did not impair subsequent memory 
in ETOH rats, provides additional evidence to suggest a relatively 
long-lasting effect of ethanol withdrawal that induces the for-
mation of strong fear memories.
The present study is the first to propose that the DCS/PROP 
administration in combination with memory retrieval can be 
a potential treatment for interference on fear memory recon-
solidation. Related to this, it should be noted that both DCS and 
PROP drugs are accepted for human use, and that the disruptive 
effect of PROP on the reconsolidation of fear and drug-related 
memories has been previously demonstrated in pre-clinical 
and clinical studies (Debiec and LeDoux, 2004; Kindt et al. 2009; 
Wouda et al., 2010; Saladin et al., 2013).
The mechanism by which DCS promotes retrieval-induced 
memory destabilization is still unknown. Mao et  al. (2008) 
reported that the DCS-induced enhancement of memory 
extinction is prevented by a proteasome inhibitor infused into 
the amygdala, suggesting that the DCS effect is mediated by 
the activation of the ubiquitin/proteasome system. Moreover, 
recent evidence has demonstrated that protein degradation in 
the hippocampus and amygdala regulates fear memory desta-
bilization after reactivation (Lee et al., 2008; Jarome et al., 2011). 
In these investigations, the proteasome inhibitor applied to 
the CA1 region of the hippocampus and amygdala following 
memory retrieval blocked the amnestic effect of anisomycin 
on memory reconsolidation. Jarome et al. (2011) demonstrated 
that ifenprodil (a NR2B-selective antagonist of the NMDA recep-
tor) reduced the amount of polyubiquitination in the amygdala 
following retrieval, suggesting that the protein degradation 
involved in memory labilization depends on NMDA receptor 
activation. Therefore, the promoting influence of pre-reacti-
vation DCS on memory destabilization in resistant memories 
might be caused by activation of the ubiquitin/proteasome sys-
tem. Further studies are needed to clarify this topic.
Recent evidence has suggested a critical role of NMDA recep-
tors on memories resistant to interference after retrieval. In 
agreement with this, Wang et al. (2009) reported that resistant 
fear memory induced by a strong conditioning protocol is asso-
ciated with a down-regulation of the NR2B receptor subunit 
in the BLA. Moreover, as mentioned above, Bustos et al. (2010) 
indicated that NMDA activation by DCS facilitated vulnerability 
to disruption after retrieval in resistant memories of stressed 
animals. Our results have indicated that this assumption can be 
extended to the resistant memory induced by ethanol depend-
ence. Furthermore, it is well known that ethanol dependence 
leads to neuroadaptive changes in the NMDA receptors from 
brain areas relevant for fear learning, such as the amygdala 
(Krystal et al., 2003; McCool et al., 2010). Therefore, it could be 
speculated that the resistance to retrieval-induced labilization 
in ETOH rats may be associated with an altered expression or 
change in the function of the NMDA receptors following ethanol 
dependence.
Central noradrenergic transmission is activated during eth-
anol withdrawal (Koob, 2008; Becker, 2012). Beta blockers such 
as PROP attenuate withdrawal symptoms and the increased 
self-administration of alcohol in dependent animals (Koob, 
2008; Gilpin and Koob, 2010). Although ethanol withdrawal 
leads to increased β-ARs density in the whole brain (Banerjee 
et al.,1978; Kuriyama et al., 1981) and to an up-regulation of cor-
tical β2-adrenoreceptor gene expression (Rimondini et al., 2002), 
the effect on these receptors in the BLA has not been reported. 
Regardless of the potential changes induced by ethanol with-
drawal on β-ARs expression, the memory destabilization facili-
tated by DCS was a crucial requirement for PROP’s disruptive 
effect on reconsolidation in ETOH rats. Although a potential 
interaction between NMDA receptors and β-ARs on memory 
reconsolidation cannot be fully discarded, further experiments 
are necessary to elucidate this possibility. As predicted, we found 
that MDZ did not affect memory of ETOH animals that had 
received DCS previous to recall. This finding is opposite to that 
reported by Bustos et al. (2010), who showed that MDZ-induced 
memory impairment in stressed rats became evident with pre-
reactivation DCS. Although stress exposure and ethanol with-
drawal can induce the formation of fear memories resistant 
to pharmacological blockade after retrieval, it seems that the 
mechanisms involved in such resistance may be different.
At this point, the question that needs answering is: why did 
MDZ not affect memory reconsolidation in DCS-pretreated ETOH 
animals? Previously, it has been demonstrated that ethanol 
dependence can induce neuroadaptive changes in the expression 
of GABAA-Rs associated with alterations in the pharmacologi-
cal responses to benzodiazepines agonists and inverse agonists 
(Papadeas et al., 2001; Cagetti et al., 2003; Diaz et al., 2011). Moreover, 
the sedative and amnestic effects of BZDs have been attributed to 
α1-containing GABAA-Rs (Mohler et al., 2002). Based on these data, 
the expression of the α1 GABAA-R subunit was evaluated in the 
BLA from the ETOH rats. As shown in Figure 7, both total and sur-
face expressions of α1 were reduced in ETOH animals. These find-
ings extend previous evidence by indicating that the reduction in 
the α1 GABAA-R subunit was evident up to the third day of ethanol 
withdrawal. Therefore, the resistance to MDZ’s disruptive effect 
on fear memory reconsolidation may have been due to, at least in 
part, the decrease of surface expression of α1 in the BLA, induced 
by chronic ethanol administration/withdrawal. Furthermore, pre-
vious findings from our laboratory demonstrated that a reduction 
of the inhibitory control mediated by GABAergic transmission in 
the BLA projection neurons leads to neuronal hyperexcitability and 
increased plasticity, which facilitates fear learning in ETOH rats 
(Isoardi et al., 2007). The neuroadaptive change in α1-containing 
GABAA-Rs observed in the present study complements these 
results, suggesting that GABAergic transmission in the BLA could 
have been altered by changes in the subunit composition of GABAA 
receptors or the associated chloride channel.
In conclusion, we have demonstrated that: (1) ethanol with-
drawal facilitated the formation of a fear memory which is 
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resistant to post-reactivation destabilization; (2) DCS pre-reac-
tivation administration facilitated the onset of a PROP, but not 
MDZ, disruptive effect on memory reconsolidation in ETOH rats; 
(3) the effect of PROP was mediated, although not exclusively, by 
β-adrenoreceptors in the BLA; and (4) the lack of MDZ´s effect on 
memory reconsolidation may have been a consequence, at least 
in part, of a reduced α1 GABAA-R subunit expression in the BLA 
induced by chronic ETOH treatment and/or its withdrawal.
Considering the critical role of negative emotional experi-
ences in the development and maintenance of psychiatric dis-
orders and drug addition, our results suggest that the blockade 
of fear memory reconsolidation by DCS/PROP treatment, in 
conjunction with memory retrieval, provides a potential treat-
ment for the attenuation of maladaptive memories involved in 
relapse following withdrawal.
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